Logo Home   Documents and Lists   Create   Site Settings   Help    Up to Department of Medicine Information
Icon
UF Cardiovascular Medicine Clinical Trials
INVEST
Folder
 
Select a View
All Documents
Manuscripts
Abstracts
  		 
Actions
  Alert me
  Export to spreadsheet
  Modify settings and columns
  		 
The contents of this web site are the property of the University of Florida and may not be included in any publications (printed or online) without written permission. You may retrieve and save these materials for educational purposes. When any pages you link to contain materials that UF doesn't own, you will need to have permission from the owner in order to copy them or link to them from your web pages. Please check each page for information (photo credits, etc.) about the owners and about permission to copy the images and documents they contain.
New New Document
|
Upload Upload Document
|
New Folder New Folder
|
Filter Filter
|
Edit in Datasheet Edit in Datasheet
 
TitleNameYear PublishedPublication TypeEdit
Count = 96
CACNA1C polymorphisms and cardiovascular outcomes in the INternational VErapamil SR/trandolapril STudy-Genetic substudy (INVEST-GENES)ClinPharmacolTher2008 83 S42008AbstractEdit Document Properties
Predicting stroke risk in hypertensive patients with coronary artery diseaseStroke2008 39 3432008ManuscriptEdit Document Properties
Impact of resting heart rate on outcomes in hypertensive patients with coronary artery diseaseEHJ2008 29 13272008ManuscriptEdit Document Properties
α-Adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: INVEST-GENESAHJ2008 156 3972008ManuscriptEdit Document Properties
Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarctionAHJ2008 156 2412008ManuscriptEdit Document Properties
Verapamil-SR strategy is comparable to atenolol strategy at reducing cardiovascular events in patients with prior myocardial infarctionJACC2007 49 232A2007AbstractEdit Document Properties
Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SRBP2007 16 suppl 12007ManuscriptEdit Document Properties
Association of CYP3A5 polymorphisms with hypertension and antihypertensive response to verapamilClinPharmacolTher2007 81 3862007ManuscriptEdit Document Properties
Missing data on the Center for Epidemiologic Studies Depression (CES-D) scale: A comparison of four imutation techniquesResSocAdminPharm2007 3 12007ManuscriptEdit Document Properties
Dual therapy in hypertensive patients with coronary artery disease: The role of calcium channel blockers and B-blockersAJCVDrugs 2007 7 252007ManuscriptEdit Document Properties
Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SRAJC2007 99 15492007ManuscriptEdit Document Properties
Influence of Hispanic ethnicity on blood pressure control and cardiovascular outcomes in women with CAD and hypertension: Findings from INVESTJWH2007 16 6322007ManuscriptEdit Document Properties
Bood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril studyHTN2007 50 2992007ManuscriptEdit Document Properties
KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INVESTPharmacogenetGenomics2007 17 7192007ManuscriptEdit Document Properties
Obesity paradox in patients with hypertension and coronary artery diseaseAJM2007 120 8632007ManuscriptEdit Document Properties
Hypertension treatment: How important is consistency of effect?HTN2007 50 2872007ManuscriptEdit Document Properties
Letters to Editor: Blood pressure levels on progression of athersoclerosisJACC2007 49 13692007MiscEdit Document Properties
Editorial: Obesity, heart disease, and favorable prognosis - Truth or paradox?AJM2007 120 8252007MiscEdit Document Properties
Increased pulse pressure is strongly associated with adverse cardiovascular outcomes in both diabetics and non diabeticsJACC2006 47 343A2006AbstractEdit Document Properties
Can an assessment of subjective well being predict outcomes in patients with hypertension and coronary artery disease?JACC2006 47 300A2006AbstractEdit Document Properties
Differences in verapamil response between CYP3A5 genotypesClinPharmacolTher2006 79 P122006AbstractEdit Document Properties
Association of angiotensin II type I receptor (AGTR1) 1166A>C polymorphism with blood pressure response to ACE inhibitor in a subgroup of patients of the INVESTClinPharmacolTher2006 79 P142006AbstractEdit Document Properties
Beta adrenergic receptors polymorphisms are assocated with response to beta-blocker therapy in the INVESTClinPharmacolTher2006 79 P302006AbstractEdit Document Properties
Lack of association of the angiotensin II type I receptor (AGTR1) 1166A>C polymorphisms with cardiovascular and cerebrovascular outcomes in a subgroup of patients of the INVESTClinPharmacolTher2006 79 P432006AbstractEdit Document Properties
KCNMB! genotype associated with cardiovascular outcomes in the INVESTClinPharmacolTher2006 79 P412006AbstractEdit Document Properties
Association of systolic blood pressure (SBP) and health related quality of life in patients with CADCirc2006 114 II-5762006AbstractEdit Document Properties
Calcium channel antagonists reduce the risk of stroke in patients with hypertension and CAD: a meta-analysisCirc2006 114_29872006AbstractEdit Document Properties
Blood pressure control and cardiovascular outcomes in high-risk Hispanic patientsAHJ2006 151 10722006ManuscriptEdit Document Properties
Depressive symptoms in coronary artery disease patients after hypertension treatmentAnn Pharmacother2006 40 5972006ManuscriptEdit Document Properties
Dogma disputed: Can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerousAnnInternMed2006 144 8842006ManuscriptEdit Document Properties
Predictors of adverse outcome among patients with hypertension and coronary artery diseaseJACC2006 47 5472006ManuscriptEdit Document Properties
Validating a self-report measure of global subjective well-being to predict adverse clinical outcomesQualityofLifeRes2006 15 6752006ManuscriptEdit Document Properties
Predictors of development of diabetes mellitus in pts with CAD taking antihypertensive medicationsAJC2006 98 8902006ManuscriptEdit Document Properties
Aggressive lowering of blood pressureLancet2006 368 6272006ManuscriptEdit Document Properties
AnnPharmacother 2006 40 5972006ManuscriptEdit Document Properties
New-Onset Diabetes2006PresentationEdit Document Properties
Outcomes in Hispanics2006PresentationEdit Document Properties
Predictors of Risk2006PresentationEdit Document Properties
BP control and CV outcomes in Hispanic and non-Hispanic women with CAD and hypertensionAJH2005 18 104A2005AbstractEdit Document Properties
Verapamil- and atenolol-based strategies are equally effective in black patients with hypertension and coronary arter diseaseAJH2005 18 109A2005AbstractEdit Document Properties
Lean body mass is associated with increased incidence of mortality and cardiovascular morbidity in hypertensive patients with coronary artery diseaseAJH2005 18 148A2005AbstractEdit Document Properties
E-prescription database analysis supports use of combination therapy in hypertensive patients with CAD in INVESTAJH2005 18 58A2005AbstractEdit Document Properties
Blood pressure control and cardiovascular outcomes in Hispanic women with coronary artery disease hypertensionCirc2005 111 E762005AbstractEdit Document Properties
Beta 2-Adrenergic Receptors (B2AR) polymorphism and anti-hypertension response to beta-blocker therapy in the INVEST trialClinPharmacolTher2005 77 P222005AbstractEdit Document Properties
Variable blood pressure response to verapamil by KCNMB1 genotypeClinPharmacolTher2005 77 P972005AbstractEdit Document Properties
Impact of heart rate on outcomes in hypertensive CAD patientsEHJ2005 26 6712005AbstractEdit Document Properties
Is office BP a meaningful measure compared to ABPM?EHJ2005 26 7532005AbstractEdit Document Properties
Impact of antihypertensive therapy on the incidence of coronary revascularization in high-risk patientsJACC2005 45 375A2005AbstractEdit Document Properties
Stroke risk inhypertensive patients with coronary artery diseaseJACC2005 45 424A2005AbstractEdit Document Properties
J curve in hypertension and coronary artery diseaseAJC2005 95 1602005ManuscriptEdit Document Properties
Calium antagonists: Effects on cardio-renal risk in hypertenstive patientsHTN2005 46 6372005ManuscriptEdit Document Properties
A drug dose model for predicting clinical outcomes in hypertensive coronary disease patientsJClinHTN2005 7 6542005ManuscriptEdit Document Properties
A study of antihypertensive drugs and depressive symptoms (SADD-Sx) in patients treated with a calcium antagonist vs an atenolol hypertension treatment strategy in the INVESTPsychosomMed2005 67 3982005ManuscriptEdit Document Properties
Global differences in blood pressure control and clinical outcomes in the INVESTClinCard2005 28 3212005ManuscriptEdit Document Properties
Association of BP control and frequency of mortality an dCV morbidity in hypertensive patients with CADAJH2004 17 116A2004AbstractEdit Document Properties
Depressive symptoms among hypertensive patients treated with verapamil-SR-led versus atenolol-led treatment strategiesAJH2004 17 122A2004AbstractEdit Document Properties
Incidence of MI is equivalent with verapamil SR-based and atenolol-based strategies in patients with hypertension and CADAJH2004 17 189A2004AbstractEdit Document Properties
All-cause mortality and cardioprotection: Equivalent efficacy of a verapamil-SR strategy compared with an atenolol strategy in hypertensive patients with CADAJH2004 17 191A2004AbstractEdit Document Properties
Risk of adverse cardiovascular outcomes and new diabetes with combination therapy in hypertensive patients with coronary artery diseaseEHJ2004 25 4232004AbstractEdit Document Properties
Verapamil-based and atenolol-based strategies result in similar cardiovascular outcomes and incidence of revascularization in hypertensive coronary artery disease patientsEHJ2004 25 6612004AbstractEdit Document Properties
Uncontrolled blood pressure is risk equivalent to diabetes and prior myocardial infarction for cardiovascular outcomesEHJ2004 25 6622004AbstractEdit Document Properties
Blood pressure control, angina episodes, and cardiovascular outcomes in patients with ischemiaJACC2004 43 483A2004AbstractEdit Document Properties
Subjective well-being and 1-year mortality and occurrence of non-fatal stroke and non-fatal myocardial infarction in patients with hypertension and coronary artery diseaseQualLifeRes2004 13 15652004AbstractEdit Document Properties
Increased pulse pressure is strongly associated with adverse cardiovascular outcomesCirc2004 110 III-6822004AbstractEdit Document Properties
Outcome benefits of BP control in older CAD patients withy hypertensionCirc2004 110 III-7312004AbstractEdit Document Properties
Clinical outcomes in the diabetes cohort of the INVESTHTN2004 44 6372004ManuscriptEdit Document Properties
Managing hypertension in European patients with coronary artery disease: Design, results, and clinical implications of INVESTIHJ2004 5 4112004ManuscriptEdit Document Properties
Cardiovascular therapies and risk for development of diabetesJACC2004 44 5092004ManuscriptEdit Document Properties
Importance of achieving lower blood pressure in hypertensive patients with diabetesHTN2004 44 6142004ManuscriptEdit Document Properties
Ischemic heart disease in women: Facts and wishful thinkingJACC2004 43 17272004ManuscriptEdit Document Properties
What is the optimal blood pressure and drug therapy for patients with coronary artery disease?JAMA2004 292 22712004ManuscriptEdit Document Properties
Characteristics of contemporary patients with hypertension and coronary artery diseaseClinCard2004 27 5712004ManuscriptEdit Document Properties
Ethnic differences in systolic blood pressure control in hypertensive patients with coronary artery diseaseAJH2003 16 27A2003AbstractEdit Document Properties
Systolic blood pressure control in diabetics and nondiabetics with hypertension and coronary artery diseaseJACC2003 41 320A2003AbstractEdit Document Properties
Comparison of depressive symptoms among CAD patients treated for hypertension with a beta-blocker- or calcium antagonist-led treatment strategyQualLifeRes2003 12 7342003AbstractEdit Document Properties
Blood pressure reduction and CV outcomes in hypertensive Hispanics, blacks, and caucasians with CADCirc2003 108 IV-4502003AbstractEdit Document Properties
Factors contributing to morbidity and mortality in contemporary CAD patients with hypertensionCirc2003 108 IV-450_CJP2003AbstractEdit Document Properties
Factors associated with lower cardiovascular event rates in women compared to men despite improved BP controlCirc2003 108 IV-6312003AbstractEdit Document Properties
Cardiovascular outcomes in diabetic patients with hypertension and CADCirc2003 108 IV-7452003AbstractEdit Document Properties
Reduced risk of new onset diabetes in hypertensive CAD patients treated with a calcium antagonist vs a beta blocker regimenCirc2003 108 IV-7502003AbstractEdit Document Properties
A calcium antagonists vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery diseaseJAMA2003 290 28052003ManuscriptEdit Document Properties
Characteristics predicing blood pressure responses in 22,599 patients with hypertension and coronary artery diseaseAJH2002 15 116A2002AbstractEdit Document Properties
Ethnicity and blood pressure control in patients with diabetes and coronary artery diseaseAJH2002 15 194A2002AbstractEdit Document Properties
Introduction: The European INVESTigators meetingClinCard2001 24 A62001Edit Document Properties
Characteristics and blood pressure responses of 6,057 Hispanic hypertensive patients with coronary artery disease enrolled in the INVESTJACC2001 37 216A2001AbstractEdit Document Properties
The vascular biology of hypertension and atherosclerosis and intervention awith calcium antagonists and angiotensin-converting enzyme inhibitorsClinCard2001 24 V12001ManuscriptEdit Document Properties
INVEST: Results of combined strategies to control blood pressureClinCard2001 24 V122001ManuscriptEdit Document Properties
Electronic prescribing via the Internet for a coronary artery disease and hypertension megatrialClinCard2001 24 V142001ManuscriptEdit Document Properties
Enhancing clinical trials on the Internet: Lessons from INVESTClinCard2001 24 V172001ManuscriptEdit Document Properties
How will INVEST and other hypertension trials change clinical practice?ClinCard2001 24 V242001ManuscriptEdit Document Properties
Characteristics of patients with coronary artery disease and hypertension: A report from INVESTClinCard2001 24 V62001ManuscriptEdit Document Properties
INVEST substudies: Design and patient characteristicsClinCard2001 24 V92001ManuscriptEdit Document Properties
Questions and answers related to the INVESTClinCard2001 24 V302001MiscEdit Document Properties
Control of blood pressure in a population of women with hypertension and CAD using an Internet-based electronic prescribing systemAJH2000 13 117A2000AbstractEdit Document Properties
A 'paper-less' study on optimal treatment strategies for hypertension and CAD: Pilot phase dataJACC1998 31 211A1998AbstractEdit Document Properties
Rationale and design of the INVEST: An Internet-based randomized trial in coronary artery disease patients with hypertensionJACC1998 32 12281998ManuscriptEdit Document Properties